CD274 and neoplasm: Tumors treated with LG268 have significantly higher PD-L1 (p = 0.005) but lower PD-1 (p = 0.02) expression compared with control mice, as determined by western blots of total tumor lysates and by immunohistochemistry of tumor sections (Fig. 6a, b and d).